0001209191-22-010393.txt : 20220216
0001209191-22-010393.hdr.sgml : 20220216
20220216200751
ACCESSION NUMBER: 0001209191-22-010393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferra Joseph J Jr
CENTRAL INDEX KEY: 0001733790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 22645287
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-14
0
0001783032
Elevation Oncology, Inc.
ELEV
0001733790
Ferra Joseph J Jr
C/O ELEVATION ONCOLOGY, INC.
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
0
1
0
0
Chief Financial Officer
Employee Stock Option (Right to Buy)
3.78
2022-02-14
4
A
0
60000
0.00
A
2032-02-13
Common Stock
60000
60000
D
The stock option vests as to 25% of the total shares on February 10, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date and is subject to acceleration in the event of a change in control of the Issuer.
/s/ Joseph Ferra
2022-02-16